Services

Today’s R&D trends are immunotherapies, personalized medicine and treatments for rare diseases. Aside from high costs tied to R&D, these treatments require advanced expertise. Developing high-tech in-house infrastructure and expanding the staff count with specific expertise is not only costly but also risky for pharmaceutical companies. Maintaining the most important core competencies, while outsourcing large parts of R&D programs to specialized, well-equipped CROs is a winning strategy.

IBR Inc. Services

Biomarkers

Read more
IBR Inc. Services

Immunogenicity

Read more
IBR Inc. Services

Cell based assays

Read more
IBR Inc. Services

Fc mediated effector functions

Read more
IBR Inc. Services

Vaccines

Read more about Vaccines
IBR Inc. Services

3D cell systems

Read more
IBR Inc. Services

Cellular immunology

Read more
IBR Inc. Services

Drug-target binding

Read more
IBR Inc. Services

Pharmacokinetics

Read more
IBR Inc. Services

Immunohistochemistry (IHC)

Read more

Submit a Question or Request
 

Simply fill out the form below and a member of our team will follow up with you shortly.

 

I accord my agreement for the usage and processing of my personal data for the purpose of processing my inquiry. I am aware that I have the right to object the processing of my data at any time and with effect for the future.